211 related articles for article (PubMed ID: 25225247)
1. Fasciola hepatica fatty acid binding protein induces the alternative activation of human macrophages.
Figueroa-Santiago O; Espino AM
Infect Immun; 2014 Dec; 82(12):5005-12. PubMed ID: 25225247
[TBL] [Abstract][Full Text] [Related]
2. Fasciola hepatica fatty acid binding protein inhibits TLR4 activation and suppresses the inflammatory cytokines induced by lipopolysaccharide in vitro and in vivo.
Martin I; Cabán-Hernández K; Figueroa-Santiago O; Espino AM
J Immunol; 2015 Apr; 194(8):3924-36. PubMed ID: 25780044
[TBL] [Abstract][Full Text] [Related]
3. Purification of Native Fasciola hepatica Fatty Acid-Binding Protein and Induction of Alternative Activation of Human Macrophages.
Figueroa-Santiago O; Espino A
Methods Mol Biol; 2020; 2137():149-169. PubMed ID: 32399927
[TBL] [Abstract][Full Text] [Related]
4. Fasciola hepatica fatty acid binding protein (Fh12) induces apoptosis and tolerogenic properties in murine bone marrow derived dendritic cells.
Ruiz-Jiménez C; Celias D; Valdés B; Ramos-Pérez WD; Cervi L; Espino AM
Exp Parasitol; 2021 Dec; 231():108174. PubMed ID: 34752732
[TBL] [Abstract][Full Text] [Related]
5. Isolation and immunological characterization of fatty acid binding protein isoforms from Fasciola hepatica.
Espino AM; Rodríguez Medina JR; Hillyer GV
J Parasitol; 2001 Oct; 87(5):1028-33. PubMed ID: 11695360
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands.
Ramos-Benítez MJ; Ruiz-Jiménez C; Aguayo V; Espino AM
Sci Rep; 2017 Jul; 7(1):5455. PubMed ID: 28710478
[TBL] [Abstract][Full Text] [Related]
7. A preliminary study to understand the effect of Fasciola hepatica tegument on naïve macrophages and humoral responses in an ovine model.
Haçarız O; Sayers G; Mulcahy G
Vet Immunol Immunopathol; 2011 Feb; 139(2-4):245-9. PubMed ID: 20850186
[TBL] [Abstract][Full Text] [Related]
8. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica.
López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A
Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471
[TBL] [Abstract][Full Text] [Related]
9. Alternative activation of ruminant macrophages by Fasciola hepatica.
Flynn RJ; Irwin JA; Olivier M; Sekiya M; Dalton JP; Mulcahy G
Vet Immunol Immunopathol; 2007 Nov; 120(1-2):31-40. PubMed ID: 17719651
[TBL] [Abstract][Full Text] [Related]
10. Possible role for Toll-like receptors in interaction of Fasciola hepatica excretory/secretory products with bovine macrophages.
Flynn RJ; Mulcahy G
Infect Immun; 2008 Feb; 76(2):678-84. PubMed ID: 18070895
[TBL] [Abstract][Full Text] [Related]
11. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD.
Martínez-Fernández AR; Nogal-Ruiz JJ; López-Abán J; Ramajo V; Oleaga A; Manga-González Y; Hillyer GV; Muro A
Vet Parasitol; 2004 Dec; 126(3):287-98. PubMed ID: 15567592
[TBL] [Abstract][Full Text] [Related]
12. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
[TBL] [Abstract][Full Text] [Related]
13. Fasciola hepatica - the pilot study of in vitro assessing immune response against native and recombinant antigens of the fluke.
Bąska P; Zawistowska-Deniziak A; Zdziarska AM; Wasyl K; Wiśniewski M; Cywińska A; Klockiewicz M; Januszkiewicz K; Wędrychowicz H
Acta Parasitol; 2013 Dec; 58(4):453-62. PubMed ID: 24338305
[TBL] [Abstract][Full Text] [Related]
14. A fatty acid binding protein from Fasciola hepatica induced protection in C57/BL mice from challenge infection with Schistosoma bovis.
Abán JL; Ramajo V; Arellano JL; Oleaga A; Hillyer GV; Muro A
Vet Parasitol; 1999 Jun; 83(2):107-21. PubMed ID: 10392967
[TBL] [Abstract][Full Text] [Related]
15. Excretory/secretory products from two Fasciola hepatica isolates induce different transcriptional changes and IL-10 release in LPS-activated bovine "BOMA" macrophages.
Bąska P; Norbury LJ; Zawistowska-Deniziak A; Wiśniewski M; Januszkiewicz K
Parasitol Res; 2017 Oct; 116(10):2775-2782. PubMed ID: 28823007
[TBL] [Abstract][Full Text] [Related]
16. Porphyromonas gingivalis lipopolysaccharide weakly activates M1 and M2 polarized mouse macrophages but induces inflammatory cytokines.
Holden JA; Attard TJ; Laughton KM; Mansell A; O'Brien-Simpson NM; Reynolds EC
Infect Immun; 2014 Oct; 82(10):4190-203. PubMed ID: 25047849
[TBL] [Abstract][Full Text] [Related]
17. The regulatory roles of Fasciola hepatica GSTO1 protein in inflammatory cytokine expression and apoptosis in murine macrophages.
Xifeng W; Jiahua Z; Ningxing L; Guowu Z; Yunxia S; Xuepeng C; Jun Q; Xianzhu X; Qingling M
Acta Trop; 2023 Sep; 245():106977. PubMed ID: 37399980
[TBL] [Abstract][Full Text] [Related]
18. Dectin-1 on macrophages modulates the immune response to Fasciola hepatica products through the ERK signaling pathway.
Guasconi L; Burstein VL; Beccacece I; Mena C; Chiapello LS; Masih DT
Immunobiology; 2018 Dec; 223(12):834-838. PubMed ID: 30197196
[TBL] [Abstract][Full Text] [Related]
19. Immunological interactions between 2 common pathogens, Th1-inducing protozoan Toxoplasma gondii and the Th2-inducing helminth Fasciola hepatica.
Miller CM; Smith NC; Ikin RJ; Boulter NR; Dalton JP; Donnelly S
PLoS One; 2009 May; 4(5):e5692. PubMed ID: 19478853
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory Effect of Fasciola hepatica Excretory-Secretory Products on Macrophages.
Guasconi L; Serradell MC; Masih DT; Chiapello LS
Methods Mol Biol; 2020; 2137():117-131. PubMed ID: 32399925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
